Glaukos Corporation

GKOS Healthcare Medical Devices

Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024.

Revenue
+58.0%
EPS
+110.7%
Free cash flow
+411.2%
Total debt
−2.25%

Quarter to September 2026, against a year earlier

225.48 5.50 +2.50%
Market cap
$13.0B
P/E
0.0×
Fwd P/E
−803×
Dividend yield
—
F-score
3/9
Altman Z
15.20
Beneish M
−2.96
Dividend safety
n/a

Glaukos Corporation (GKOS) Book value per share

Alert me on Book value per share

Glaukos Corporation's book value per share at the end of fiscal 2025 was 11.5×, down 21.1% from 14.5× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 12.1×. Over the past ten years it has ranged from 3.6× (fiscal 2016) to 18.0× (fiscal 2019); the current reading is higher than 64% of that period. Glaukos Corporation ranks 31st of 149 Medical Devices companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 11.5× (21.08%)
FY2024 14.5× 52.48%
FY2023 9.5× (14.65%)
FY2022 11.2× (11.67%)
FY2021 12.6× (15.68%)
FY2020 15.0× (16.78%)
FY2019 18.0× 266.12%
FY2018 4.9× 22.47%
FY2017 4.0× 12.87%
FY2016 3.6× (34.62%)

Quarterly newest first

Period Book value per share Change
Sep 2026 12.1× 4.59%
Jun 2026 11.6× 0.35%
Mar 2026 11.6× 0.79%
Dec 2025 11.5× (14.42%)
43 more quarters

Against its own ten years

Low 3.6× High 18.0×
Ten-year median 11.2×
Current reading's percentile 64

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on GKOS